Kwan Chiu-Yin, Zhang Wen-Bo, Sim Si-Mui, Deyama Takeshi, Nishibe Sansei
HSC-4N40, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, L8 N 3Z5, Canada.
Naunyn Schmiedebergs Arch Pharmacol. 2004 May;369(5):473-80. doi: 10.1007/s00210-004-0927-4. Epub 2004 Apr 17.
Siberian ginseng (SG) has been widely and historically consumed as a health food product for the improvement of self well-being, but whether vascular relaxation may contribute to such a therapeutic health effect has not been studied. We therefore investigated the vasorelaxant effect of the aqueous extract of the roots of SG (Eleutherococcus senticosus Maxim) using several in vitro vascular rings prepared from dog carotid artery, rat aorta and rat mesenteric artery. SG extract (0.04-0.8 mg/ml) caused concentration-dependent relaxation in dog carotid arterial rings pre-contracted with 100 microM phenylephrine (PE), and the relaxation was primarily endothelium-dependent. Treatment with 100 microM L-NOARG (a nitric oxide synthase inhibitor) either prevented or totally reverted SG-induced relaxation, suggesting that the endothelium-dependent relaxation was mediated by NO. Similar endothelium-dependent vascular relaxant responses were also obtained with rat aortic and mesenteric arterial rings, except that it occurred over a relatively higher concentration range of SG (0.5-2.0 mg/ml). When tested in the presence of 300 microM L-NAME, the vasorelaxant effect of SG was inhibited totally in rat aorta but only partially in rat mesenteric artery. The relaxation to SG that was insensitive to L-NAME in rat mesenteric arterial rings was eliminated when the rings (both proximal and distal ends) were pre-treated with a combination of 300 microM L-NAME and 15 mM KCl indicating the involvement of endothelium-derived hyperpolarizing factor (EDHF). This vasorelaxant response of the SG extract was inhibited partially by atropine (1 microM), completely by TEA (5 mM), but not by indomethacin (1 microM) or propranolol (10 microM). SG up to 2 mg/ml had no effect on KCl-induced contraction in any of the vascular rings studied. When compared with carbachol-induced (CCh) relaxation, SG resembles CCh in that the sensitivity to L-NAME inhibition is dependent on vascular size, i.e. aorta >proximal end of mesenteric artery >distal end of mesenteric artery. However, SG exhibited different potencies to relaxation while CCh showed similar potency (EC(50) of about 0.2 microM) in all three vascular segments. In conclusion, we have demonstrated that the vascular effect of SG is endothelium-dependent and mediated by NO and/or EDHF depending on the vessel size. Other vasorelaxation pathways, such as inhibition of K(+)-channels and activation of muscarinic receptors, may also be involved.
西伯利亚人参(SG)长期以来一直被广泛用作保健食品,以改善自身健康状况,但血管舒张是否有助于产生这种治疗性健康效果尚未得到研究。因此,我们使用从狗颈动脉、大鼠主动脉和大鼠肠系膜动脉制备的几种体外血管环,研究了SG(刺五加)根的水提取物的血管舒张作用。SG提取物(0.04 - 0.8毫克/毫升)使预先用100微摩尔苯肾上腺素(PE)预收缩的狗颈动脉环产生浓度依赖性舒张,且这种舒张主要依赖于内皮。用100微摩尔L - NOARG(一种一氧化氮合酶抑制剂)处理可预防或完全逆转SG诱导的舒张,这表明内皮依赖性舒张是由一氧化氮介导的。在大鼠主动脉和肠系膜动脉环中也获得了类似的内皮依赖性血管舒张反应,只是在相对较高浓度范围的SG(0.5 - 2.0毫克/毫升)下才出现。当在300微摩尔L - NAME存在下进行测试时,SG在大鼠主动脉中的血管舒张作用被完全抑制,但在大鼠肠系膜动脉中仅部分被抑制。当用300微摩尔L - NAME和15毫摩尔氯化钾的组合预处理大鼠肠系膜动脉环(近端和远端)时,对L - NAME不敏感的SG诱导的舒张被消除,这表明内皮衍生的超极化因子(EDHF)参与其中。SG提取物的这种血管舒张反应被阿托品(1微摩尔)部分抑制,被TEA(5毫摩尔)完全抑制,但不受吲哚美辛(1微摩尔)或普萘洛尔(10微摩尔)影响。高达2毫克/毫升的SG对所研究的任何血管环中氯化钾诱导的收缩均无影响。当与卡巴胆碱诱导的(CCh)舒张进行比较时,SG与CCh相似之处在于对L - NAME抑制的敏感性取决于血管大小,即主动脉>肠系膜动脉近端>肠系膜动脉远端。然而,SG在舒张方面表现出不同的效力,而CCh在所有三个血管段中显示出相似的效力(EC50约为0.2微摩尔)。总之,我们已经证明SG的血管作用是内皮依赖性的,并且根据血管大小由一氧化氮和/或EDHF介导。其他血管舒张途径,如抑制钾通道和激活毒蕈碱受体,也可能参与其中。